A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F)
Clinical trial NCT03525548 · COMPLETED
Trial details
- NCT number
- NCT03525548
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2018-12-28
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.